Short answer
aTYR PHARMA INC (ATYR) filed an 8-K current report with the SEC on November 13, 2026 reporting Item 8.01 (Other Events). Nasdaq minimum bid-price compliance restored after shares closed at least $1.00 for 10 consecutive business days.
aTYR PHARMA INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Nasdaq minimum bid-price compliance restored after shares closed at least $1.00 for 10 consecutive business days
- Compliance period ran October 30 through November 12, 2026
- Delisting risk from Nasdaq Listing Rule 5550(a)(2) removed, with no outstanding Nasdaq deficiency notices
- Prior 180-day extension would have expired November 30, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other aTYR PHARMA INC 8-K filings
Get the next ATYR 8-K as it lands
Follow ATYR for push alerts, or ask the research agent what this filing means.